Fennec Pharmaceuticals (FENC) Shares Outstanding (2010 - 2025)

Fennec Pharmaceuticals' Shares Outstanding (Entity) history runs 16 years deep, the most recent figure standing at $34.2 million for Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 24.11% year-over-year to $34.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $34.2 million (up 24.11% YoY) and the FY2025 annual result came in at $34.2 million, up 24.11% from the prior year.
• Shares Outstanding (Entity) was $34.2 million for Q4 2025 at Fennec Pharmaceuticals, up from $28.1 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $34.2 million in Q4 2025 and bottomed at $26006.0 in Q4 2021.
• A 5-year average of $25.8 million and a median of $26.6 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) slumped 99.9% — and 2022, when it soared 101265.07%.
• Fennec Pharmaceuticals' Shares Outstanding (Entity) stood at $26006.0 in 2021, then surged by 101265.07% to $26.4 million in 2022, then grew by 2.53% to $27.0 million in 2023, then rose by 1.85% to $27.5 million in 2024, then gained by 24.11% to $34.2 million in 2025.
• Business Quant data shows FENC's Shares Outstanding (Entity) at $34.2 million in Q4 2025, $28.1 million in Q3 2025, and $27.7 million in Q2 2025.